$935 million Plexxikon buy to bolster Daiichi Sankyo's oncology presence
01 March 2011
Ian Haydock
Please Login to read the full article.
01 March 2011
Ian Haydock
Please Login to read the full article.
RELATED CONTENT
NEWS
- Roche/Plexxikon's Zelboraf secures EU approval for personalised skin cancer medicine
- New research sheds more light on secondary tumours with Roche/Plexxikon's Zelboraf
- BMS, Roche team up to tackle melanoma in combination drug approach
- Biotech vets come out blazing as new biosimilars venture Coherus links with Daiichi Sankyo
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
